Observational studies have previously reported a higher risk for venous thromboembolism (VTE) in people who use nonsteroidal anti-inflammatory drugs (NSAIDs) than in those who don’t use NSAIDs. However, authors of a new study of more than 7 million patien... See more
Neurodiverse patients are often diagnosed with cancer at later stages and have worse outcomes, various studies have shown. The contributing factors are myriad, but among them is the fact that both oncologists and patients may be unaware of the neurodiverg... See more
On Dec. 12,the U.S. Food and Drug Administration (FDA) announced that it approved niraparib and abiraterone acetate (Akeega) with prednisone for adult patients with deleterious or suspected deleterious BRCA2-mutated (BRCA2m) metastatic castration-sensitiv... See more
On Dec. 8, the U.S. Food and Drug Administration (FDA) announced that it approved omidubicel-onlv (Omisirge), the first hematopoietic stem cell transplant (HSCT) therapy indicated to treat patients who have severe aplastic anemia (SAA), a rare and potenti... See more
On November 25, the U.S. Food and Drug Administration (FDA) approved durvalumab (Imfinzi) combined with the standard-of-care chemotherapy as neoadjuvant and adjuvant treatment, followed by durvalumab monotherapy, for adults with resectable, early-stage, a... See more
